Clinical Trials Logo

Clinical Trial Summary

The goal of this study is to compare the efficacy and drawbacks of Heparin and Hirudin in Haemodialysis patients. The main question it aims to answer is: which drug is more safe in Haemodialysis?


Clinical Trial Description

Extracorporeal thrombogenesis is a major problem associated with haemodialysis. The composition of the artificial membrane in the extracorporial system and large surface area to which the blood is exposed, contribute significantly to activation of the coagulation cascade and platelets. The use of anticoagulant is to prevent thrombotic occlusion of the dializer to ensure effective dialysis. The most common anticoagulant options for Hemodialysis include unfractionated heparin (UFH), low-molecular weight heparin (LMWH), thrombin antagonists, and platelet inhibiting agents. The choice of anticoagulant for Haemodialysis should be determined by patient characteristics, local expertise, and ease of monitoring. Heparins are currently the anticoagulants of choice in long-term haemodialysis (HD), but because of their shortcomings, including the increasing incidence of heparin-induced thrombocytopenia (HIT II), alternative anticoagulation is necessary, as there are several complication associated with its long term use, They include thrombocytopenia, increase bleeding tendency, osteoporosis, increase lipolytic activity and change of lipid pattern, activation of of lipolysis also leads to immunosuppressive effect. Hirudin the most potent natural inhibitor of thrombin, it is a direct thrombin inhibitor and does not require endogenous cofactors. Hirudin inhibits all actions of thrombin and so effectively inhibit coagulation and prevent heparin resistant arterial type thrombosis when given in large enough doses. Hirudin has no adverse effect when it is used into human, because it is pharmacologically inert. Hirudin is also a weak immunogen. Few researches evaluate the efficacy and drawbacks of Hirudin in HD patients. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06112262
Study type Interventional
Source Assiut University
Contact Basma Rabiey, Master
Phone 01128066349
Email basmarabiey639@gmail.com
Status Not yet recruiting
Phase Early Phase 1
Start date December 20, 2023
Completion date September 2026

See also
  Status Clinical Trial Phase
Completed NCT01224314 - Potassium in Haemodialysis Fluids and Haemodynamics N/A
Not yet recruiting NCT05525234 - A Study of Thalidomide in the Treatment of Refractory Uremic Pruritus Phase 4
Active, not recruiting NCT04139525 - Comparison of Citrate and Heparin Anticoagulation During Hemodialysis With MCO PES-PVP (Theranova) Membrane N/A
Completed NCT02887742 - Epidemiologic Study and Impact Study of a Dialysis Solution Change on the Electrocardiographic Profile of Patient N/A
Completed NCT01163981 - Ultrasound Guided Cannulation of Dialysis Fistulas N/A
Recruiting NCT02902848 - Evaluation of the Validity of the Prothrombin Time Internation Normalised Ratio (PT/INR) Measured at the point-of Care on the Arterial Bloodline of Haemodialysis Extracorporeal Blood Flow N/A
Completed NCT00718289 - Citrate- Versus Acetate-Based Dialysate in Bicarbonate Haemodialysis: Consequences on Haemodynamics, Coagulation, Acid-Base Status and Electrolytes Phase 4
Not yet recruiting NCT06225544 - Lumasiran in Hyperoxalaemic Patients on Haemodialysis Phase 2
Completed NCT02707757 - Treatment Response in Dialysis Anaemia Phase 4
Terminated NCT01382888 - Efficacy and Local Tolerability of Topically Applied Heparin on the Suitability of Newly Constructed Primary Arteriovenous Fistulas in Patients Planned for Haemodialysis Phase 2
Recruiting NCT00829153 - U Clip Study - Study to Compare U Clip Anastomosis With Conventional Continuous Prolene Anastomosis Phase 1/Phase 2
Completed NCT00230906 - Uremic Toxin Removal With a New High Flux Cellulose Triacetate Membrane N/A
Not yet recruiting NCT05128188 - SASH: Sodium Accumulation Study In Haemodialysis
Completed NCT05729997 - Live Classical Music and the Response to the Disease and Its Evolution in Patients With Chronic Renal Failure N/A
Active, not recruiting NCT02063776 - Haemodiafiltration vs Conventional Haemodialysis in Children N/A
Completed NCT05280106 - Citrate Dialysate in Online Hemodialfiltration N/A
Recruiting NCT04842591 - Characteristics of Pulmonary Vascular Changes in Patients With Kidney Transplantation
Recruiting NCT04247867 - Combination of Medium Cut-off Dialyzer Membrane and Diet Modification to Alleviate Residual Uremic Syndrome of Dialysis Patients N/A
Recruiting NCT04260412 - The Effect of Combining Medium Cut Off Dialysis Membrane and Diet Modification on Reducing of Inflammation Response N/A
Completed NCT00388661 - Melatonin and Quality of Life in Dialysis Patients Phase 3